Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 2

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Treatments

Drug: LAAM

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000356
Y01-3-0012-5
NIDA-3-0012-5

Details and patient eligibility

About

The purpose of this study is to determine the pharmacokinetics of L-alpha-acetylmethadol (LAAM) in adults transferred from methadone maintenance treatment for opiate dependence.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems